Bloomberg News

Pfizer, France’s INRA to Work Together on Animal-Health Research

February 02, 2012

Feb. 2 (Bloomberg) -- France’s National Institute for Agricultural Research said it signed an agreement with Pfizer Inc. to boost research cooperation in veterinary medicine.

The agreement will make it easier to set up future partnerships and research contracts, and includes plans to share knowledge and expertise, the Paris-based researcher, known by its acronym INRA, wrote today in an online statement.

The research cooperation could lead to jointly filed and owned patents, INRA said. The institute said it already works with Pfizer on finding treatments for bacteria that cause mammary infections in cows and new ways to treat parasitic infections in cattle, sheep and goats.

“This agreement is expected to facilitate cooperation between the institute and the leading company in veterinary pharmaceuticals in the framework of future research contracts,” INRA said.

Claire Lauvernier, a Pfizer spokeswoman, confirmed the cooperation agreement today. She did not provide further details.

INRA and Pfizer may work together on developing vaccines and treatments for infectious diseases, knowledge about viruses, bacteria and parasites that cause illnesses, as well as genetics and animal immunity, the French researcher wrote.

--Editors: Sharon Lindores, John Deane

-0- Feb/02/2012 10:52 GMT

-0- Feb/02/2012 17:11 GMT

To contact the reporter on this story: Rudy Ruitenberg in Paris at rruitenberg@bloomberg.net

To contact the editor responsible for this story: Claudia Carpenter at ccarpenter2@bloomberg.net -0- Feb/02/2012 10:31 GMT


Tim Cook's Reboot
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus